Literature DB >> 6725481

Activated alpha-alkyl-alpha-arylacetic acid enantiomers for stereoselective thin-layer chromatographic and high-performance liquid chromatographic determination of chiral amines.

H Weber, H Spahn, E Mutschler, W Möhrke.   

Abstract

The separation of racemic benoxaprofen into the two benoxaprofen enantiomers by preparative high-performance liquid chromatography and the application of the activated enantiomers as derivatization reagents for the simultaneous stereoselective determination of chiral amines in biological material is described. Activated (+)- and (-)-benoxaprofen are both shown to be very sensitive and stable chiral fluorescence markers, applicable to thin-layer chromatography as well as to high-performance liquid chromatography.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6725481     DOI: 10.1016/s0378-4347(00)84081-5

Source DB:  PubMed          Journal:  J Chromatogr


  5 in total

1.  Liquid chromatographic estimation of tranylcypromine in human plasma.

Authors:  P G Krugers Dagneaux; C P Loohuis; J T Klein Elhorst; T S Van der Veer
Journal:  Pharm Weekbl Sci       Date:  1992-04-24

2.  Influence of probenecid on the urinary excretion rates of the diastereomeric benoxaprofen glucuronides.

Authors:  H Spahn; S Iwakawa; L Z Bevet; E T Lin
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1987 Oct-Dec       Impact factor: 2.441

Review 3.  Chromatographic separation of enantiomers.

Authors:  K G Feitsma; B F Drenth
Journal:  Pharm Weekbl Sci       Date:  1988-02-19

4.  Enantiospecific high-performance liquid chromatographic (HPLC) determination of baclofen and its fluoro analogue in biological material.

Authors:  H Spahn; D Krauss; E Mutschler
Journal:  Pharm Res       Date:  1988-02       Impact factor: 4.200

5.  Procedures to characterize in vivo and in vitro enantioselective glucuronidation properly: studies with benoxaprofen glucuronides.

Authors:  H Spahn; S Iwakawa; E T Lin; L Z Benet
Journal:  Pharm Res       Date:  1989-02       Impact factor: 4.200

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.